Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Biopharma Segment — Depreciation & amortization by Year
Biopharma Segment — Depreciation & amortization ($M) ($M)
Pfizer Biopharma Segment — Depreciation & amortization: $1,379M in FY2025, up 1.4% from a year earlier. That is the highest of the 9 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Note 17 — Segment Reporting (ASU 2023-07 Significant Segment Expenses).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biopharma Segment — Depreciation & amortization ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,379 | +1.4% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 1,360 | +12.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 1,213 | +9.6% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 1,107 | +40.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 789 | +13.9% | Form 10-K (filed 2024-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 693 | -29.1% | Form 10-K (filed 2023-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 978 | +2.6% | Form 10-K (filed 2022-02-24) ↗ |
| FY2018 | Dec 31, 2018 | 953 | +8.2% | Form 10-K (filed 2020-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 881 | – | Form 10-K (filed 2020-02-27) ↗ |
Cite this data
StockData. (2026). Pfizer Biopharma Segment — Depreciation & amortization ($M), annual FY2017–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/seg-da-bio
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.